The apparent diffusion coefficient is a useful biomarker in predicting treatment response in patients with locally advanced rectal cancer
Acta Radiologica Open · 2020-09 · 9 (9)
DOI: 10.1177/2058460120957295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Radiologica Open, online erschienen am 15.09.2020. Verfasst von Mayra Evelia Jiménez de Los Santos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, National Cancer Institute, Mexico City, Mexico. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Apparent diffusion coefficient (ADC) values achieve promising results in treatment response prediction in patients with several types of cancers.
Purpose
To determine whether ADC values predict neoadjuvant chemoradiation treatment (nCRT) response in patients with locally advanced rectal cancer (LARC). Material and Methods Forty-four patients with LARC who underwent magnetic resonance imaging scans before and after nCRT followed by delayed surgery were enrolled retrospectively. The sample was distributed as follows: responders (R), n = 8; and non-responders (Non-R), n = 36. Three markers of treatment response were considered: post-nCRT measures; ΔADC; and Δ%ADC. Statistical analysis included a Wilcoxon test, a Mann–Whitney U test, and a receiver operating characteristic (ROC) analysis in order to evaluate the diagnostic accuracy for each ADC value marker to differentiate between R and Non-R.
Results
Both minimum and mean ADC values were significantly higher after nCRT in the R group, while non-significant differences between basal and control ADC values were found in the non-R group. In addition, ΔADC and Δ%ADC exhibited increased values after nCRT in R when compared with non-R. ROC analysis revealed the following diagnostic performance parameters: post-nCRT: ADC min = 1.05 × 10 −3 mm 2 /s (sensitivity 61.1% and specificity 66.7%), ADC mean = 1.50 × 10 −3 mm 2 /s (sensitivity 72.2% and specificity 83.3%), ΔADC: ADC min = 0.35 (sensitivity 66.7% and specificity 83.3%), ADC mean = 0.50 (sensitivity 72% and specificity 83%); and Δ%ADC: ADC min = 44% (sensitivity 66.7% and specificity 83.3%) and ADC mean = 60% (sensitivity 83% and specificity 99%).
Conclusion
Our findings suggest that post-treatment rectal tumor ADC values, as well changes between pre- and post-treatment values, may be biomarkers for predicting treatment response in patients with LARC who underwent nCRT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, National Cancer Institute, Mexico City, Mexico.
- Department of Surgical Oncology, National Cancer Institute, Mexico City, Mexico.
ORCID-Profile: Isabel Sollozo-Dupont
Zitieren
APA
Jiménez de Los Santos, M. E., Reyes-Pérez, J. A., Sandoval-Nava, R. M., Villalobos-Juárez, J. L., Villaseñor-Navarro, Y., Vela-Sarmiento, I., & Sollozo-Dupont, I. (2020). The apparent diffusion coefficient is a useful biomarker in predicting treatment response in patients with locally advanced rectal cancer. Acta Radiologica Open, 9(9). https://doi.org/10.1177/2058460120957295
Vancouver
Jiménez de Los Santos ME, Reyes-Pérez JA, Sandoval-Nava RM, Villalobos-Juárez JL, Villaseñor-Navarro Y, Vela-Sarmiento I, et al. The apparent diffusion coefficient is a useful biomarker in predicting treatment response in patients with locally advanced rectal cancer. Acta Radiologica Open. 2020;9(9). doi:10.1177/2058460120957295
BibTeX
@article{JimnezdeLosSantos2020,
author = {Jiménez de Los Santos, Mayra Evelia and Reyes-Pérez, Juan Armando and Sandoval-Nava, Rosa Martha and Villalobos-Juárez, José Luis and Villaseñor-Navarro, Yolanda and Vela-Sarmiento, Itzel and Sollozo-Dupont, Isabel},
title = {The apparent diffusion coefficient is a useful biomarker in predicting treatment response in patients with locally advanced rectal cancer},
journal = {Acta Radiologica Open},
year = {2020},
volume = {9},
number = {9},
doi = {10.1177/2058460120957295}
}
EUVIMED